Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Idenix Pharmaceuticals reports interim phase II and other data on anti-HCV treatments

May 14, 2010

TransVax CMV vaccine safe and immunogenic up to 1 year in HSCT patients

May 14, 2010

Preclinical data support safety and potent antitumor activity of C-BiTE antibody

May 14, 2010

VGX-100 enhances antitumor effects of bevacizumab/docetaxel in vivo

May 14, 2010

Merck KGaA identifiies novel oral heat shock protein 90 inhibitors for cancer

May 14, 2010

Novel extended-release, tamper-resistant formulation of oxycodone shows favorable PK

May 14, 2010

Phase III data on AIDSVAX gp120 B/E and ALVAC vCP1521 show protective effect

May 13, 2010

Seasonal flu vaccine VAX-125 immunogenic in elderly subjects

May 13, 2010

FLT3/ITD kinase inhibitors ITRI-260 and ITRI-376 potential candidates for AML treatment

May 13, 2010

Eotaxin serum levels, retinal expression increased in age-related macular degeneration

May 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...